As of October 30, 2025, the average one-year price target for Altimmune is $18.81/share. The forecasts range from a low of $1.01 to a high of $29.40. The average price target represents an increase of ...
Fintel reports that on February 28, 2025, William Blair initiated coverage of Altimmune (NasdaqGM:ALT) with a Market Perform recommendation. As of February 19, 2025, the average one-year price target ...
Fintel reports that on November 7, 2025, Citizens maintained coverage of Altimmune (NasdaqGM:ALT) with a Market Outperform recommendation. Analyst Price Forecast Suggests 358.86% Upside As of October ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results